Literature DB >> 21190291

KLF1 directly coordinates almost all aspects of terminal erythroid differentiation.

Michael R Tallack1, Andrew C Perkins.   

Abstract

The molecular events and transcriptional mechanisms that underlie erythropoiesis are of great interest to biologists and hematologists since disorders of erythrocytes are common and remain relatively poorly understood. Kruppel-like factor 1 (KLF1) is a critical transcription factor for erythropoiesis in mice and man. Recently the use of chromatin immunoprecipitation (ChIP) coupled to next-generation DNA sequencing (ChIP-seq) has led to an updated understanding of how KLF1 functions in vivo. The full extent of KLF1 target genes have provided new insights into erythropoiesis, and have established that KLF1 controls almost all aspects of erythroid cell development and maturation.
© 2010 IUBMB.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21190291     DOI: 10.1002/iub.404

Source DB:  PubMed          Journal:  IUBMB Life        ISSN: 1521-6543            Impact factor:   3.885


  39 in total

1.  KLF1-null neonates display hydrops fetalis and a deranged erythroid transcriptome.

Authors:  Graham W Magor; Michael R Tallack; Kevin R Gillinder; Charles C Bell; Naomi McCallum; Bronwyn Williams; Andrew C Perkins
Journal:  Blood       Date:  2015-02-27       Impact factor: 22.113

2.  Neomorphic effects of the neonatal anemia (Nan-Eklf) mutation contribute to deficits throughout development.

Authors:  Antanas Planutis; Li Xue; Cecelia D Trainor; Mohan Dangeti; Kevin Gillinder; Miroslawa Siatecka; Danitza Nebor; Luanne L Peters; Andrew C Perkins; James J Bieker
Journal:  Development       Date:  2017-02-01       Impact factor: 6.868

Review 3.  Orchestration of late events in erythropoiesis by KLF1/EKLF.

Authors:  Merlin Nithya Gnanapragasam; James J Bieker
Journal:  Curr Opin Hematol       Date:  2017-05       Impact factor: 3.284

4.  Ldb1-nucleated transcription complexes function as primary mediators of global erythroid gene activation.

Authors:  LiQi Li; Johannes Freudenberg; Kairong Cui; Ryan Dale; Sang-Hyun Song; Ann Dean; Keji Zhao; Raja Jothi; Paul E Love
Journal:  Blood       Date:  2013-04-22       Impact factor: 22.113

Review 5.  The multifunctional role of EKLF/KLF1 during erythropoiesis.

Authors:  Miroslawa Siatecka; James J Bieker
Journal:  Blood       Date:  2011-05-25       Impact factor: 22.113

Review 6.  EKLF/KLF1, a tissue-restricted integrator of transcriptional control, chromatin remodeling, and lineage determination.

Authors:  Yvette Y Yien; James J Bieker
Journal:  Mol Cell Biol       Date:  2012-10-22       Impact factor: 4.272

7.  RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation.

Authors:  Olga N Kuvardina; Julia Herglotz; Stephan Kolodziej; Nicole Kohrs; Stefanie Herkt; Bartosch Wojcik; Thomas Oellerich; Jasmin Corso; Kira Behrens; Ashok Kumar; Helge Hussong; Henning Urlaub; Joachim Koch; Hubert Serve; Halvard Bonig; Carol Stocking; Michael A Rieger; Jörn Lausen
Journal:  Blood       Date:  2015-04-24       Impact factor: 22.113

8.  Simvastatin and t-butylhydroquinone suppress KLF1 and BCL11A gene expression and additively increase fetal hemoglobin in primary human erythroid cells.

Authors:  Elizabeth R Macari; Emily K Schaeffer; Rachel J West; Christopher H Lowrey
Journal:  Blood       Date:  2012-12-06       Impact factor: 22.113

9.  Generation of mice deficient in both KLF3/BKLF and KLF8 reveals a genetic interaction and a role for these factors in embryonic globin gene silencing.

Authors:  Alister P W Funnell; Ka Sin Mak; Natalie A Twine; Gregory J Pelka; Laura J Norton; Tania Radziewic; Melinda Power; Marc R Wilkins; Kim S Bell-Anderson; Stuart T Fraser; Andrew C Perkins; Patrick P Tam; Richard C M Pearson; Merlin Crossley
Journal:  Mol Cell Biol       Date:  2013-05-28       Impact factor: 4.272

Review 10.  Ldb1 complexes: the new master regulators of erythroid gene transcription.

Authors:  Paul E Love; Claude Warzecha; LiQi Li
Journal:  Trends Genet       Date:  2013-11-27       Impact factor: 11.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.